Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Walker

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|August 20, 1983
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinomaK J Walker, R I Nicholson, A O Turkes, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
Hormone Research|January 1, 1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancerR I Nicholson, K J Walker, R F Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
Journal of the American Geriatrics Society|September 1, 1993
Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factorsK J Walker, S S Gilliland, K Vance-Bryan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferationR I Nicholson, N Bouzubar, K J Walker, et al.
British Journal of Cancer|June 1, 1989
Ki67 immunostaining in primary breast cancer: pathological and clinical associationsN Bouzubar, K J Walker, K Griffiths, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
Cancer Research|November 15, 1988
Immunocytochemical localization of estrogen receptor in human breast tissueK J Walker, N Bouzubar, J Robertson, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|August 20, 1983
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinomaK J Walker, R I Nicholson, A O Turkes, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
Hormone Research|January 1, 1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancerR I Nicholson, K J Walker, R F Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
Journal of the American Geriatrics Society|September 1, 1993
Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factorsK J Walker, S S Gilliland, K Vance-Bryan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferationR I Nicholson, N Bouzubar, K J Walker, et al.
British Journal of Cancer|June 1, 1989
Ki67 immunostaining in primary breast cancer: pathological and clinical associationsN Bouzubar, K J Walker, K Griffiths, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
Cancer Research|November 15, 1988
Immunocytochemical localization of estrogen receptor in human breast tissueK J Walker, N Bouzubar, J Robertson, et al.
Pageof 5